Literature DB >> 35975263

GIANT MEDIASTINAL PARATHYROID ADENOMAS AND MULTIPLE ENDOCRINE NEOPLASIA TYPE 1: A DIAGNOSTIC CONUNDRUM.

A Gautam1, A Rastogi1, S K Bhadada1.   

Abstract

Context: Giant parathyroid adenoma (GPA) is a rare entity that is rarer with Multiple endocrine neoplasia type 1 (MEN1) syndrome.
Objectives: Describe the clinical presentation, diagnostic difficulties, and management strategy for GPA in MEN1.
Methods: We searched Pubmed, SCOPUS and EMBASE for GPA in MEN1 for GPA in association with MEN1. Hereby, we describe index case of largest ever reported GPA.
Results: We identified 7 cases of GPA reported till date in association with MEN1. The mean adenoma weight was 7.1 gram. The index case is largest-ever reported GPA (weight 97 gram) in MEN1 presenting with compressive symptoms and mediastinal mass. Incidentally, she was found to have hypercalcemia with increased parathyroid hormone, suggesting primary hyperparathyroidism. The possibilities of an ectopic parathyroid tumor and thymic carcinoid were considered. She also had acromegaloid features, and was found to have a sellar tumor. Subsequently, MENIN gene mutation was identified confirming MEN1 syndrome. Patient underwent trans-sternal excision of the mass weighing 97 grams and confirmed as parathyroid adenoma on histopathologic examination.
Conclusion: Despite rarity of ectopic mediastinal parathyroid tumors, calcium profile should be considered as part of work-up of considering varied etiologies of anterior mediastinal mass. ©2021 Acta Endocrinologica (Buc).

Entities:  

Keywords:  Giant Parathyroid adenoma; Hypercalcemia; MEN1 Syndrome; Neuroendocrine tumor; Parathyroid adenoma

Year:  2022        PMID: 35975263      PMCID: PMC9365420          DOI: 10.4183/aeb.2022.118

Source DB:  PubMed          Journal:  Acta Endocrinol (Buchar)        ISSN: 1841-0987            Impact factor:   1.104


  27 in total

1.  Thymic carcinoid and parathyroid hyperplasia detection with 99mTc-MIBI men type 1.

Authors:  C Marí; J León; J Farrerons; X Matis-Guiu; A Tembl; J C Martin; A Flotats; L l Bernà
Journal:  J Endocrinol Invest       Date:  1999-11       Impact factor: 4.256

2.  Surgical treatment of hyperparathyroidism in patients with multiple endocrine neoplasia type 1.

Authors:  Laura A Lambert; Suzanne E Shapiro; Jeffrey E Lee; Nancy D Perrier; Mylene Truong; Michael J Wallace; Ana O Hoff; Robert F Gagel; Douglas B Evans
Journal:  Arch Surg       Date:  2005-04

3.  MEN1 disease occurring before 21 years old: a 160-patient cohort study from the Groupe d'étude des Tumeurs Endocrines.

Authors:  P Goudet; A Dalac; M Le Bras; C Cardot-Bauters; P Niccoli; N Lévy-Bohbot; H du Boullay; X Bertagna; P Ruszniewski; F Borson-Chazot; B Vergès; J L Sadoul; F Ménégaux; A Tabarin; J M Kühn; P d'Anella; O Chabre; S Christin-Maitre; G Cadiot; C Binquet; B Delemer
Journal:  J Clin Endocrinol Metab       Date:  2015-01-16       Impact factor: 5.958

4.  Clonality of parathyroid tumors in familial multiple endocrine neoplasia type 1.

Authors:  E Friedman; K Sakaguchi; A E Bale; A Falchetti; E Streeten; M B Zimering; L S Weinstein; W O McBride; Y Nakamura; M L Brandi
Journal:  N Engl J Med       Date:  1989-07-27       Impact factor: 91.245

5.  A large functioning parathyroid cyst in a patient with multiple endocrine neoplasia type 1.

Authors:  Hiroyuki Tamiya; Megumi Miyakawa; Hisanori Suzuki; Akira Takeshita; Kenichi Ohashi; Takeshi Usui; Daishu Miura; Yasuhiro Takeuchi
Journal:  Endocr J       Date:  2013-02-02       Impact factor: 2.349

6.  Hypercalcaemia caused by a carcinoid tumour.

Authors:  M M Brzozowska; L Wolmarans; J V Conaglen
Journal:  Intern Med J       Date:  2009-06       Impact factor: 2.048

7.  Do giant parathyroid adenomas represent a distinct clinical entity?

Authors:  Philip M Spanheimer; Andrew J Stoltze; James R Howe; Sonia L Sugg; Geeta Lal; Ronald J Weigel
Journal:  Surgery       Date:  2013-08-23       Impact factor: 3.982

8.  HIGH RISK OF PARATHYROID CARCINOMA AND GENETIC SCREENING IN THE FIRST DIAGNOSED ROMANIAN FAMILY WITH HYPERPARATHYROIDISM-JAW TUMOR SYNDROME AND A GERMLINE MUTATION OF THE CDC73 GENE.

Authors:  D Grigorie; A Sucaliuc; S Ciuffi; F Franceschelli; F Marini; D Ioachim; D Terzea; M L L Brandi
Journal:  Acta Endocrinol (Buchar)       Date:  2019 Jul-Sep       Impact factor: 0.877

9.  Novel association of MEN1 gene mutations with parathyroid carcinoma.

Authors:  Luigia Cinque; Angelo Sparaneo; Filomena Cetani; Michelina Coco; Celeste Clemente; Massimiliano Chetta; Teresa Balsamo; Claudia Battista; Eliana Sanpaolo; Elena Pardi; Leonardo D'Agruma; Claudio Marcocci; Evaristo Maiello; Geoffrey N Hendy; David E C Cole; Alfredo Scillitani; Vito Guarnieri
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

10.  Octreotide uptake in parathyroid adenoma.

Authors:  Seyhan Karaçavuş; Mustafa Kula; Züleyha Cihan Karaca; Kürşad Unlühızarcı; Ahmet Tutuş; Fahri Bayram; Ganime Coban
Journal:  Mol Imaging Radionucl Ther       Date:  2012-08-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.